RxDoctor Payments DataLook up a doctor →

Justin Arambasick, MD

Emergency Medicine · Dayton, OHNPI 1497995658

Payments from drug & device makers

$2,267,252in general payments, 2019–2025

Across 1,585 payments — averaging $1430.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$670K
  • AstraZeneca$628K
  • Novo Nordisk AS$543K
  • Amgen$309K
  • Genentech, Inc.$57K
  • Boehringer Ingelheim$22K
  • plus $38K from 9 others
$535in research payments, 2019–2025

Across 1 payment — averaging $535.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$535

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,267,252 in reported general payments places this provider in the 95th percentile of 2,431 emergency medicine providers in Ohio.

See all emergency medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$9,896
Medicare patients
60
Services billed
74

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →